Search

Author/Creator Natsios, Athanasios

1. Clinical Effectiveness of First‐Line Anti‐TNF Therapies and Second‐Line Anti‐TNF Therapy Post‐Vedolizumab Discontinuation in Patients With Ulcerative Colitis or Crohn's Disease: 638. (October 2019)

Authors:
Bressler, Brian; Yarur, Andres; Kopylov, Uri; Bassel, Marielle; Brett, Neil R.; Lissoos, Trevor; Lopez, Claudia; Natsios, Athanasios; Saha, Sumit; Kifnidi, Christina; Demuth, Dirk; Patel, Haridarshan; Mantzaris, Gerassimos J.
Journal:
American journal of gastroenterology
Issue:
Volume 114 (2019)ACG Abstracts 1:Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Real World Safety of Vedolizumab and Anti‐TNF Therapies in Biologic‐Naϊve Ulcerative Colitis and Crohn's Disease Patients: Results From the EVOLVE Study: 795. (October 2019)

Authors:
Yarur, Andres; Mantzaris, Gerassimos J.; Kopylov, Uri; Bassel, Marielle; Brett, Neil R.; Lissoos, Trevor; Lopez, Claudia; Natsios, Athanasios; Kifnidi, Christina; Saha, Sumit; Demuth, Dirk; Patel, Haridarshan; Bressler, Brian
Journal:
American journal of gastroenterology
Issue:
Volume 114 (2019)ACG Abstracts 1:Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search